Table 3

Literature review on PEToma

StudyNo. patientsFocal, no. (%)DiffuseFurther examinationFNAC/operationCancer, no. (%)Pathology (micro)SUV
Cohen et al.64 52571 (1.6)31NA15/NA7 (47.0)3 PTC
2 poorly differentiated PTC
Useful
Kim et al.94 13645 (1.1)45NA32/718 (56.0)14 PTC
2 metastatic
2 follicular thyroid cancer
NS
Chen et al.74 80360 (1.2)507 (14.0)7 PTCUseful
Choi et al.81 76370 (4.0)4429/NA17 (38.6)16 PTCUseful
Are et al.58 800101 (1.1)1625757/2724 (42.0)19 PTCNS
Chu et al.116 24176 (1.2)14/14 (28.6)4 PTCNA
Bogsrud et al.107 34779 (1.1)48NA/1115 (31.3)12 PTC
2 metastatic
NS
King et al.1615 71122 (0.1)2121/147 (32.0)6 PTC (4)
1 MTC
NA
Nishimori et al.*4 726103 (2.2)575030/109 (30.0)8 PTC (2)
1 poorly differentiated PTC
NS
  • FNAC = fine-needle aspiration cytology; MCT = medullary thyroid cancer; NA = not available; NS = not significant; PTC = papillary thyroid cancer; SUV = standardized uptake value.

  • * Unpublished data, 2008.